Skip to main content

Table 1 Diagnostic performance of significant echocardiography and CMR parameters for the detection of malignancy and tumor on pathology

From: Diagnostic performance of CMR and transthoracic echocardiography in clinical evaluation of cardiac masses with histopathological correlation

  Accuracy Sensitivity Specificity PPV NPV
Echocardiography
Tumor (n=31)      
1. Location outside the right atrium 72.7% (32/44) 71.0% (22/31) 76.9% (10/13) 88.0% (22/25) 52.6% (10/19)
2. Location outside the atria and ventricles 50.0% (22/44) 29.0% (9/31) 100% (13/13) 100% (9/9) 37.1%(13/35)
Malignant Tumor (n=17)      
1. Location outside the atria and ventricles 77.3% (34/44) 47.1% (8/17) 96.3% (26/27) 88.9% (8/9) 74.3% (26/35)
2. Non-Mobility 72.7% (32/44) 82.5% (14/17) 66.7% (18/27) 60.9% (14/23) 85.7% (18/21)
3. Pericardial effusion 75.0% (33/44) 52.9% (9/17) 88.9% (24/27) 75.0% (9/12) 75.0% (24/32)
CMR
Tumor (n=35)      
1. Location outside the right atrium 72.0% (36/50) 77.1% (27/35) 60.0% (9/15) 81.8% (27/33) 52.9% (9/17)
2. T2 Hyperintensity or Mixed Pattern 76.0% (38/50) 88.6% (31/35) 46.7% (7/15) 79.5% (31/39) 63.6% (7/11)
3. Contrast Enhancement on First Pass 86.0% (43/50) 82.9% (29/35) 93.3% (14/15) 96.7% (29/30) 70.0% (14/20)
4. Late Gadolinium Enhancement 86.0% (43/50) 85.7% (30/35) 86.7% (13/15) 93.8% (30/32) 72.2% (13/18)
Malignant Tumor (n=21)      
1. Location outside the atria and ventricles 76.0% (38/50) 61.9% (13/21) 86.2% (25/29) 76.5% (13/17) 75.8% (25/33)
2. Non-Mobility 78.0% (39/50) 95.2% (20/21) 65.5% (19/29) 66.7% (20/30) 95.0% (19/20)
3. Contrast Enhancement on First Pass 70.0% (35/50) 85.7% (18/21) 58.6% (17/29) 60.0% (18/30) 85.0% (17/20)
4. Late Gadolinium Enhancement 66.0% (33/50) 85.7% (18/21) 51.7% (15/29) 56.3% (18/32) 83.3% (15/18)
5. Myocardial Invasion 72.0% (36/50) 33.3% (7/21) 100% (29/29) 100% (7/7) 67.4% (29/43)
6. Pericardial Effusion 76.0% (38/50) 47.6% (10/21) 96.6% (28/29) 90.9% (10/11) 71.8% (28/39)